
A life sciences venture fund investing in biotechnology and biopharma companies across multiple stages

Life sciences venture fund backing biotech and biopharma companies from seed to later stage across three regions

Novartis Bioventures is a life sciences investor, operating as the Novartis Venture Fund. It makes equity investments in biotechnology and biopharma businesses, mainly those developing new therapeutics and platforms. The fund is not tied to one stage and invests from seed rounds through later financing.
Biotechnology and biopharma companies in North America, Europe and Israel.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
As of 2026-10-12. Organic ranks only; sponsored placements are never ranks.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Novartis Bioventures.
Similar listings buyers compare against this one.

A life sciences venture fund investing in biotechnology and biopharma companies across multiple stages

A family office investing its own capital in real estate, renewable energy and credit

Venture capital firm investing in founders heading toward a Series A round, based outside Silicon Valley

Growth equity investor backing climate technology companies that speed up the energy transition

Los Angeles investment adviser managing long/short portfolios of biotechnology and medical device stocks

Family office investing in sustainable real estate and built-environment innovation in Finland and the Baltics
Everything here links back to the same verified catalogue. Pick your next stop.